Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer.
about
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic responseAlternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools.Multifunctional nanoparticles for co-delivery of paclitaxel and carboplatin against ovarian cancer by inactivating the JMJD3-HER2 axis.Synergistic Effects of NOTCH/γ-Secretase Inhibition and Standard of Care Treatment Modalities in Non-small Cell Lung Cancer Cells
P2860
Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer.
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Pathobiological implications o ...... f HER2-positive breast cancer.
@ast
Pathobiological implications o ...... f HER2-positive breast cancer.
@en
type
label
Pathobiological implications o ...... f HER2-positive breast cancer.
@ast
Pathobiological implications o ...... f HER2-positive breast cancer.
@en
prefLabel
Pathobiological implications o ...... f HER2-positive breast cancer.
@ast
Pathobiological implications o ...... f HER2-positive breast cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Pathobiological implications o ...... f HER2-positive breast cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2016.338
P407
P50
P577
2016-09-19T00:00:00Z
P6179
1011889328